Literature DB >> 7341547

EMG changes in chronically dialyzed uraemic subjects undergoing d, 1-Carnitine treatment.

P M Rossini, L Marchionno, D Gambi, M Pirchio, G Del Rosso, A Albertazzi.   

Abstract

The deficiency of muscle Carnitine secondary to chronic dialysis frequently induces lipid storage in striated muscles associated with progressive myocardial involvement. Serial EMG recordings disclose the presence of several motor unit potential families in tibialis anterior muscle related to damage of peripheral nervous fibres and muscular districts due to the storage of lipid vacuoles. The administration of d,1-Carnitine to twenty chronically dialyzed uraemic patients significantly improved distal latency of the M response of the external peroneal nerve at the EDB muscle and the MUP properties suggesting a Carnitine-dependent amelioration of fatty acid oxidative processes both in muscle and Schwann cells. The main side effects following d,1-Carnitine oral administration (3 g/daily) is a myasthenia-like symptom complex that is promptly reversed on drug interruption.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341547     DOI: 10.1007/bf02335405

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  23 in total

1.  The electromyogram in myopathy: analysis with the audio-frequency spectrometer.

Authors:  J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1952-11       Impact factor: 10.154

2.  The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity.

Authors:  V K Nielsen
Journal:  Acta Med Scand       Date:  1973-11

3.  Latencies recorded by intramuscular needle electrodes in different portions of a muscle: variation and comparison with surface electrodes.

Authors:  M R Horning; G H Kraft; A Guy
Journal:  Arch Phys Med Rehabil       Date:  1972-05       Impact factor: 3.966

4.  The estimation of conduction velocity in human skeletal muscle in situ with surface electrodes.

Authors:  H Nishizono; Y Saito; M Miyashita
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-06

5.  Oral treatment of carnitine myopathy.

Authors:  G P Hosking; N P Cavanagh; D P Smyth; J Wilson
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

6.  A quantitative electrophysiological study of uraemic neuropathy. Diabetic and renal neuropathies compared.

Authors:  S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

7.  Carnitine "deficiency": lack of response to carnitine therapy.

Authors:  J E Carroll; M H Brooke; D C DeVivo; J B Shumate; R Kratz; S P Ringel; J M Hagberg
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

8.  Fatal cases of lipid storage myopathy with carnitine deficiency.

Authors:  F Cornelio; S Di Donato; D Peluchetti; A Bizze; B Bertagnolio; A D'Angelo; U Wiesmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

9.  The pharmacology of d- and l-carnitine and d- and l-acetylcarnitine. Comparison with choline and acetylcholine.

Authors:  K Blum; E Seifter; J Seifter
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

10.  Proximal muscle weakness in uremia. Case reports and review of the literature.

Authors:  R P Lazaro; H S Kirshner
Journal:  Arch Neurol       Date:  1980-09
View more
  1 in total

Review 1.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.